MetaADEDB 2.0 @ LMMD
gamma-Aminobutyric Acid
(BTCSSZJGUNDROE-UHFFFAOYSA-N)
Structure
SMILES
NCCCC(=O)O
Type(s)
Approved; Investigational
Molecular Formula:
C4H9NO2
Molecular Weight:
103.120
Log P:
0.5102
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
63.32
CAS Number(s):
20-79-1; 56-12-2; 20791
Synonym(s)
1.
gamma-Aminobutyric Acid
2.
4-Aminobutyric Acid
3.
GABA
4.
4-Aminobutanoic Acid
5.
Aminalon
6.
Aminalone
7.
Gammalon
8.
Lithium GABA
9.
gamma-Aminobutyric Acid, Calcium Salt (2:1)
10.
gamma-Aminobutyric Acid, Hydrochloride
11.
gamma-Aminobutyric Acid, Monolithium Salt
12.
gamma-Aminobutyric Acid, Monosodium Salt
13.
gamma-Aminobutyric Acid, Zinc Salt (2:1)
14.
4 Aminobutanoic Acid
15.
4 Aminobutyric Acid
16.
Acid, Hydrochloride gamma-Aminobutyric
17.
GABA, Lithium
18.
Hydrochloride gamma-Aminobutyric Acid
19.
gamma Aminobutyric Acid
20.
gamma Aminobutyric Acid, Hydrochloride
21.
gamma Aminobutyric Acid, Monolithium Salt
22.
gamma Aminobutyric Acid, Monosodium Salt
External Link(s)
MeSHD005680
PubChem Compound6992099
119
BindingDB24183
ChEBI16865
59888
CHEMBLCHEMBL96
DrugBankDB02530
DrugCentral1262
IUPHAR/BPS Guide to PHARMACOLOGY5410
1067
KEGGcpd:C00334
dr:D00058
Therapeutic Target DatabaseD0D3ID
D0C9XA
D04QAC
ZINC1532620
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug administration errorFAERS: 3US FAERS
2FatigueFAERS: 3US FAERS
3PainFAERS: 3US FAERS
4Blood creatinine increasedFAERS: 2US FAERS
5ChillsFAERS: 2US FAERS
6DizzinessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
7Medication ErrorFAERS: 2US FAERS
8Nonspecific reactionFAERS: 2US FAERS
9PneumoniaFAERS: 2US FAERS
10AtelectasisFAERS: 1US FAERS
11Blood creatine phosphokinase increasedFAERS: 1US FAERS
12Blood urea increasedFAERS: 1US FAERS
13Chest PainFAERS: 1US FAERS
14Chest discomfortFAERS: 1US FAERS
15Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
16Culture urine positiveFAERS: 1US FAERS
17Ear discomfortFAERS: 1US FAERS
18HeadacheFAERS: 1US FAERS
19Incorrect dose administeredFAERS: 1US FAERS
20InfectionFAERS: 1US FAERS
21InfluenzaFAERS: 1US FAERS
22Joint swellingFAERS: 1US FAERS
23LethargyFAERS: 1US FAERS
24Lymphocyte count decreasedFAERS: 1US FAERS
25Lymphocyte percentage decreasedFAERS: 1US FAERS
26MalaiseFAERS: 1US FAERS
27Musculoskeletal stiffnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
28MyalgiaFAERS: 1US FAERS
29Myoglobin blood increasedFAERS: 1US FAERS
30Neonatal aspirationFAERS: 1US FAERS
31Neutrophil percentage increasedFAERS: 1US FAERS
32Night sweatsFAERS: 1US FAERS
33Product label issueFAERS: 1US FAERS
34Product measured potency issueFAERS: 1US FAERS
35Product name confusionFAERS: 1US FAERS
36Product packaging issueFAERS: 1US FAERS
37PruritusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
38Pulmonary EmbolismFAERS: 1US FAERS
39Pulmonary HypertensionFAERS: 1US FAERS
40Rash erythematousFAERS: 1US FAERS
41RestlessnessFAERS: 1US FAERS
42SepsisFAERS: 1US FAERS
43SyncopeFAERS: 1US FAERS
44TremorFAERS: 1US FAERS
45Unevaluable eventFAERS: 1US FAERS
46VomitingFAERS: 1US FAERS
47Wrong drug administeredFAERS: 1US FAERS
48Ataxia19747469CTD
49Bradycardia

View details

CTD
50Catalepsy707139
6771794
CTD
51Catatonia2823166
3938209
CTD
52Cocaine-Related Disorders15135161CTD
53Epilepsy10219272
19474175
CTD
54ErythemaCanada Vigilance: 1Canada Vigilance
55Glucose Metabolism Disorders25456265CTD
56Hemiplegia3683725CTD
57Hypotension1451572
6621821
CTD
58Manganese Poisoning18771689CTD
59Movement Disorders2727012CTD
60NauseaCanada Vigilance: 1Canada Vigilance
61Schizophrenia18757185CTD
62Seizures

View details

CTD
63Status Epilepticus1969357
8474571
8817469
CTD
64Substance Withdrawal Syndrome10690749CTD
65Tachycardia2541852CTD
66UrticariaCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.